Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapy Optimisation for the Treatment of Hairy Cell Leukemia
NCT02131753Phase 3Recruiting
- Sponsor
- Justus Liebig University Giessen
- Start
- May 2004
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cladribine in hairy cell leukemia (HCL), sponsored by Justus Liebig University Giessen. Started May 2004; status: recruiting.
02
Drugs
cladribine
03
Conditions
hairy cell leukemia (HCL)
Beyond the preview
Go deeper on NCT02131753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02131753.